1. India Stocks

  2. •

    Health technology

  3. •

    Pharmaceuticals: major
Sunil Healthcare Ltd.

Sunil Healthcare Ltd.

70.00
INR
+0.05
(+0.07%)
3.47EPS
19.32P/E
687.07MMarket Cap
Sunil Healthcare Ltd.
BSE:SUNLOC
(Bombay Stock Exchange)

Recent

price

70.00

P/E

ratio

19.32

div

yld

- -

ROIC.AI

2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
INR
41.77
44.99
59.37
70.31
78.9
98.36
87.28
78.24
67.81
88.08
116.2
107.71
87.92
81.31
85.29
81.86
Revenue per Share
2.11
1.41
3.2
3.88
5.1
4.91
4.38
-0.67
-4.84
-0.62
6.26
6.52
-1.74
-1.38
3.91
3.47
Basic EPS, GAAP
-0.65
-3.26
4.99
-1.93
-6.54
-2.45
-9.88
8.92
3.41
9.89
13.14
3.19
-25.22
2.04
18.1
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
17.97
19.37
22.55
25.23
30.29
41.84
46.26
45.61
43.49
42.63
48.71
54.61
66.52
65.4
67.87
- -
Book Value per Share
17.89
19.28
22.34
25.06
30.13
41.52
45.98
45.3
43.25
42.44
48.55
54.49
66.44
65.36
67.85
- -
Tangible Book Value per Share
10
10
10
10
10
10
10
10
10
10
10
10
10
10
10
10
Basic Weighted Avg Shares
428
461
609
721
809
1,009
895
802
695
903
1,192
1,105
902
834
875
841
Sales/Revenue/Turnover
11.39
7.53
14.36
11.36
13.51
10.92
10.87
6.96
-14.35
5.16
13.82
11.08
-1.35
7.96
9.53
7.35
Operating Margin (%)
32
38
41
40
38
43
48
57
61
61
63
70
61
64
64
62
Depreciation Expense
22
14
33
40
52
50
45
-7
-50
-6
64
67
-18
-14
40
36
Net Income, GAAP
33.9
33.95
35.93
35.33
34.93
36.23
28.79
- -
- -
- -
30.7
29.54
- -
- -
- -
- -
Effective Tax Rate (%)
5.06
3.13
5.39
5.52
6.46
4.99
5.02
-0.86
-7.14
-0.71
5.39
6.05
-1.98
-1.7
4.58
4.24
Profit Margin (%)
-19
-20
18
39
26
5
7
-86
-72
-50
-50
26
52
25
75
- -
Working Capital
24
43
38
57
92
128
183
97
120
148
110
86
189
179
137
- -
LT Debt
184
199
231
259
311
429
474
468
446
437
500
560
682
671
696
- -
Total Equity
- -
3.74
7.68
8.52
8.76
7.15
7.15
- -
- -
- -
9.4
9.65
- -
- -
- -
- -
Return on Invested Capital (%)
- -
7.19
11.03
11.47
12.26
9.72
7.83
- -
- -
- -
9.24
10.25
- -
- -
- -
- -
Return on Capital (%)
- -
7.54
15.26
16.25
18.36
13.6
9.95
-1.47
-10.86
-1.44
13.71
12.61
-2.88
-2.09
5.86
- -
Return on Common Equity (%)

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
403
- -
LT Borrowings
- -
137
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
10
10
10
Market Capitalization
744
635
687

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
739
- -
Cash, Cash Equivalents & STI
- -
1
- -
Accounts Receivable, Net
- -
451
- -
Inventories
- -
187
- -
Total Current Liabilities
- -
663
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
403
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
9.09%
10.05%
3.78%
Free Cash Flow
-7.51%
-50.8%
788.66%
Net Income, GAAP
-123.2%
-326.56%
-382.79%
Sales/Revenue/Turnover
2.32%
0.72%
4.9%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
215
203
205
212
834
2026
226
235
218
197
875
2027
190
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
-0.67
-0.53
-0.53
0.35
-1.38
2026
0.89
0.97
0.57
1.48
3.91
2027
0.45
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -
Similar Companies
Eli Lilly and Company (NYSE:LLY)
Novo Nordisk A/S (NYSE:NVO)
Johnson & Johnson (NYSE:JNJ)
Pfizer, Inc. (NYSE:PFE)
Dr. Reddy's Laboratories Ltd. (NSE:DRREDDY)
Divi's Laboratories Limited (NSE:DIVISLAB)
Business
Sunil Healthcare Limited manufactures empty hard gelatin capsule shells, vegetable capsules, pullulan capsules, and HPMC vegan capsules under the Sunloc brand; it offers specialized features including double lock, triple lock, multiple groove designs, liner options, circular printing, two-color printing, and 360-degree printing across nine sizes with a production capacity of 13 billion capsules per annum. The company, founded in 1973 and headquartered in New Delhi, India, with manufacturing facilities in Alwar, Rajasthan, operates primarily in the pharmaceutical packaging sector, serving domestic and global markets as the second-largest producer of empty hard shell gelatin capsules in India. In recent developments, Sunil Healthcare appointed Mr. Jai Prakash Singh as an additional non-executive independent director effective February 13, 2025, for a five-year term; approved remuneration for Chairman and Managing Director Mr. Anil Kumar Khaitan through March 31, 2027; and named M/s. ATCS & Associates as secretarial auditors for five years and M/s. MUFG Intime India Private Limited for e-voting services at its 51st annual general meeting held on September 29, 2025.